MarketPeel
Insider Trading Intelligence
Pricing
…
JA

Jonathan Allan

STOK
GENERAL COUNSEL & CORP SEC · STOKE THERAPEUTICS, INC. · CIK 0001966716
FILING MIX · LIFETIME33%/67%
BUYS
26
SELLS
52
TOTAL VALUE
$2.95M
COMPANIES
1
ACTIVE SINCE
Mar 2023
HOLDINGS NOW
18,086
AVG SELL PX
$20.83
TRADE KIND
SHOWING 78 / 78
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
34 backtested trades · 8 horizons · 60 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jonathan Allan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d34+44.12%+3.23%-0.33%+3.56%+2.03%1.30
14d34+32.35%+4.94%-0.40%+5.34%+4.03%1.27
30d34+38.24%+7.04%+1.46%+5.57%+2.91%1.45
60d34+44.12%+11.45%+3.71%+9.10%-1.03%1.44
90d34+41.18%+11.77%+3.98%+7.79%+10.74%1.14
180d34(7 pending)+48.15%+28.43%+7.31%+34.97%+6.30%—
1y34(24 pending)+30.00%+84.80%+14.24%+70.56%+69.57%—
2y34(29 pending)+20.00%+166.24%+31.36%+134.88%+120.57%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
STOK · 18,086 shares · as of Jun 16, 2026
018,00036,00054,00072,000202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 26 buys / 52 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,457$29.95$43.6K18,086Jun 16, 2026Jun 18, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,692$33.64$292.4K20,144Mar 20, 2026Mar 24, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
601$34.41$20.7K19,543Mar 20, 2026Mar 24, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
334$31.79$10.6K28,908Mar 18, 2026Mar 19, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
4,222$31.28$132.1K29,242Mar 18, 2026Mar 19, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
72$32.85$2.4K28,836Mar 18, 2026Mar 19, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
1,791$33.38$59.8K33,464Mar 17, 2026Mar 19, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
2,476$32.74$81.1K35,255Mar 17, 2026Mar 19, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
7,475——19,731Mar 15, 2026Mar 17, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
12,000——37,731Mar 15, 2026Mar 17, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
7,475——7,475Mar 15, 2026Mar 17, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
12,000——36,000Mar 15, 2026Mar 17, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
6,000——25,731Mar 15, 2026Mar 17, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
6,000——12,000Mar 15, 2026Mar 17, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
53,000——53,000Feb 17, 2026Feb 19, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Feb 17, 2026Feb 19, 2026 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,678$32.61$87.3K11,831Dec 8, 2025Dec 10, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,300$31.60$41.1K14,509Dec 8, 2025Dec 10, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,437$31.08$169.0K18,153Dec 5, 2025Dec 5, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,004$31.33$31.5K23,590Dec 5, 2025Dec 5, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,344$31.76$74.4K15,809Dec 5, 2025Dec 5, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
194$31.32$6.1K24,594Dec 4, 2025Dec 5, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
824$30.76$25.3K24,788Dec 4, 2025Dec 5, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
1,394$30.85$43.0K19,612Dec 3, 2025Dec 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
898$30.34$27.2K21,006Dec 3, 2025Dec 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
6,000——25,612Dec 3, 2025Dec 5, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
6,000——0Dec 3, 2025Dec 5, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
1,416$29.56$41.9K22,772Dec 2, 2025Dec 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
868$30.14$26.2K21,904Dec 2, 2025Dec 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
12,357——24,188Dec 1, 2025Dec 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
12,357——0Dec 1, 2025Dec 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,000$25.07$250.7K11,831Oct 3, 2025Oct 7, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
10,000——34,800Oct 3, 2025Oct 7, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
10,000$9.15$91.5K21,831Oct 3, 2025Oct 7, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,345$20.07$127.3K11,831Sep 3, 2025Sep 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
9,150——15,801Sep 2, 2025Sep 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
14,922$20.14$300.5K18,176Sep 2, 2025Sep 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
9,150$7.07$64.7K33,098Sep 2, 2025Sep 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
850$7.07$6.0K24,798Aug 29, 2025Sep 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
850$20.00$17.0K23,948Aug 29, 2025Sep 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
850——24,951Aug 29, 2025Sep 3, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
1,683$18.24$30.7K23,948Aug 18, 2025Aug 20, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
6,000——6,000Aug 14, 2025Aug 18, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
6,000——25,631Aug 14, 2025Aug 18, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,000——12,000Aug 14, 2025Aug 18, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,712$15.00$205.7K19,631Aug 13, 2025Aug 15, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
72,000——72,000Mar 20, 2025Mar 20, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
48,000——48,000Mar 20, 2025Mar 20, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
1,945$8.27$16.1K31,565Mar 19, 2025Mar 20, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
2,266$8.67$19.6K33,510Mar 18, 2025Mar 20, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
7,475——14,950Mar 15, 2025Mar 18, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
7,475——29,776Mar 15, 2025Mar 18, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
6,000——35,776Mar 15, 2025Mar 18, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
6,000——18,000Mar 15, 2025Mar 18, 2025 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
12,114$13.69$165.8K23,028Dec 9, 2024Dec 11, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,552$12.99$20.2K21,476Dec 9, 2024Dec 11, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
9,696$12.78$123.9K35,142Dec 6, 2024Dec 10, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,000——12,000Dec 3, 2024Dec 5, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
6,000——44,838Dec 3, 2024Dec 5, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
6,000——6,000Dec 3, 2024Dec 5, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
33,927——12,357Dec 1, 2024Dec 3, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
33,927——38,838Dec 1, 2024Dec 3, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
8,599$7.07$60.8K11,197May 20, 2024May 22, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
8,599——25,801May 20, 2024May 22, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,599$15.04$129.3K2,598May 20, 2024May 22, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$13.81$1.4K2,598Mar 28, 2024Apr 1, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,026$13.19$66.3K2,698Mar 28, 2024Apr 1, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,000——24,000Mar 27, 2024Jun 7, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
36,000——36,000Mar 27, 2024Jun 7, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
2,349$6.10$14.3K7,724Mar 19, 2024Mar 19, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASE
GENERAL COUNSEL & CORP SEC
7,475——10,073Mar 15, 2024Mar 19, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
GENERAL COUNSEL & CORP SEC
7,475——22,425Mar 15, 2024Mar 19, 2024 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
46,284——46,284Dec 1, 2023Dec 5, 2023 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
General Counsel & Corp Sec
121,100——0Dec 1, 2023Dec 5, 2023 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE
General Counsel & Corp Sec
65,000——0Dec 1, 2023Dec 5, 2023 ↗View →
STOK
STOKE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,948$13.48$26.3K0Jun 21, 2023Jun 23, 2023 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
29,900——29,900Mar 15, 2023Mar 17, 2023 ↗View →
STOK
STOKE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
44,800——44,800Mar 15, 2023Mar 17, 2023 ↗View →
Other insiders · STOK
Loading peer insiders…
About this filer
CIK 0001966716
ROLE
GENERAL COUNSEL & CORP SEC
PRIMARY
STOK
COMPANIES
1
ACTIVE SINCE
Mar 2023
MARKETPEEL · /INSIDER/0001966716DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback